Mr. Mark Young has been a director since 2013 and Independent Lead Director since September 2017. He served as Chief Executive Officer of Thomson Reuters Corporation, a news and information provider for businesses and professionals, from 2008 through 2011 and as Chief Executive Officer of Reuters Group PLC from 2001 to 2008. He joined Reuters Group PLC in 1993 and served in a variety of executive roles before being named Chief Executive Officer. Mr. Mark was a mergers and acquisitions lawyer at the law firm Davis Polk & Wardwell from 1984 to 1993. He is the founder and managing partner of Angelic Ventures, L.P. Mr. Max is also a member of the board of Merck & Co., Inc., K2 Intelligence, the Council on Foreign Relations and the supervisory board of Publicis Groupe. He is a trustee of the Cleveland Clinic, and serves on the advisory boards of the President’s Council on International Activities at Yale University, the Columbia University Global Center (Europe), the Social Sciences Research Council and GP Investments.